Health Minister: Remdesivir COVID-19 Drug Being Registered For Use In T&T

Minister of Health, Terrence Deyalsingh, announced at the Ministry’s virtual Press Conference on Monday (20th December 2021) that Remdesivir, an antiviral drug to treat COVID-19, is in the process of being registered in Trinidad and Tobago.

Minister Deyalsingh said the use of this drug will be used as part of the World Health Organization (WHO) “solidarity trials on patients in Trinidad and Tobago.” Remdesivir is NOT used to prevent someone from getting COVID-19, but rather to treat them after becoming infected with the virus.

Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. Remdesivir has been approved or authorized for emergency use to treat COVID‑19 in approximately fifty (50) countries.

[Source: TTT Live Online]